What You Should Know:
– Cybin Inc. (NYSE American: CYBN), a company developing next-generation psychedelic therapies for mental health, has secured $150M in a private placement of common shares led by Deep Track Capital and…
Continue Reading
What You Should Know:
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).The acquisition marks a major step forward in AstraZeneca delivering on its ambition to…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
Clinical trials technology company Science 37 went public during the Covid-19 pandemic, a time when drug developers readily embraced technologies that enable patients to participate in drug studies from their homes. Decentralized clinical trials…
Continue Reading
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science…
Continue Reading
What You Should Know:
– AstraZeneca has announced the acquisition of Icosavax, a biopharmaceutical company developing a promising vaccine targeting both RSV and hMPV, for a total of up to $1.1 billion.
– This acquisition strengthens…
Continue Reading
What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
What You Should Know:
Data Driven Insights Enabled by Merck and Amgen Fundings
As the most extensive repository of its kind, this data lake empowers biopharmaceutical companies by providing crucial insights necessary for advancing diagnostic and…
Continue Reading
What You Should Know:
– AstraZeneca, a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals,…
Continue Reading
